Your fact-checks will appear here
Sciences that admit of absolute precision in their results
Cologuard and its new version, Cologuard Plus, are designed and FDA‑approved specifically to detect colorectal cancer (CRC) and precancerous lesions by finding tumor DNA and blood in stool; Exact Scie...
Cologuard’s original multitarget stool DNA test detects roughly 92% of colorectal cancers in average‑risk screening studies but produces positive results in about 13% of people who do not have cancer ...
The Cologuard multitarget stool DNA test analyzes *stool collected in the patient’s large specimen container for DNA markers*, while the fecal immunochemical component (FIT) that detects occult blood ...